Document Detail


How cancer metabolism is tuned for proliferation and vulnerable to disruption.
MedLine Citation:
PMID:  23151579     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cancer metabolism has received a substantial amount of interest over the past decade. The advances in analytical tools have, along with the rapid progress of cancer genomics, generated an increasingly complex understanding of metabolic reprogramming in cancer. As numerous connections between oncogenic signalling pathways and metabolic activities emerge, the importance of metabolic reprogramming in cancer is being increasingly recognized. The identification of metabolic weaknesses of cancer cells has been used to create strategies for treating cancer, but there are still challenges to be faced in bringing the drugs that target cancer metabolism to the clinic.
Authors:
Almut Schulze; Adrian L Harris
Related Documents :
23796249 - The role of phenolic compounds in the fight against cancer - a review.
22458989 - Depressive mood and subsequent cancer diagnosis in patients undergoing a colonoscopy.
24204789 - Functional genetic polymorphisms in pp2a subunit genes confer increased risks of lung c...
24591759 - Annexin a2: its molecular regulation and cellular expression in cancer development.
23554909 - Restoration of mir-1228* expression suppresses epithelial-mesenchymal transition in gas...
22844369 - Identification of clinicopathological factors predicting lymph node metastasis in diffe...
20380279 - Duodenal obstruction by self-expanding biliary stents in patients with pancreatic cancer.
2300499 - Body weight and physical activity as predictors of colorectal cancer risk.
6546609 - The bio-social elements of risk in the invasive cervical cancer incidence among a stati...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Nature     Volume:  491     ISSN:  1476-4687     ISO Abbreviation:  Nature     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-15     Completed Date:  2012-11-30     Revised Date:  2014-02-20    
Medline Journal Info:
Nlm Unique ID:  0410462     Medline TA:  Nature     Country:  England    
Other Details:
Languages:  eng     Pagination:  364-73     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cell Proliferation
Humans
Lipids / biosynthesis
Mitochondria / metabolism
Neoplasms / diagnosis,  metabolism*,  physiopathology,  therapy
Oncogenes / physiology
Signal Transduction
Tumor Suppressor Proteins / metabolism
Grant Support
ID/Acronym/Agency:
11359//Cancer Research UK; //Cancer Research UK
Chemical
Reg. No./Substance:
0/Lipids; 0/Tumor Suppressor Proteins
Comments/Corrections
Erratum In:
Nature. 2013 Feb 7;494(7435):130

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Central nervous system control of metabolism.
Next Document:  Mitochondrial disorders as windows into an ancient organelle.